Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation
Balawant Kumar1, Rizwan Ahmad1, Giovanna A Giannico2
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, 985870 Nebraska Medical Center, Omaha, NE, 68198-5870, USA.
Background:
Claudin-2 expression is upregulated in multiple cancers and promotes cancer malignancy. Remarkably, the regulation of claudin-2 expression in kidney cell lines contrasts its reported regulation in other organs. However, claudin-2 role in renal clear cell carcinoma (RCC) remains unknown despite its predominant expression in the proximal tubular epithelium (PTE), the site of RCC origin.
Methods:
Publicly available and independent patient databases were examined for claudin-2 association with RCC. The novel protein function was validated in vitro and in vivo by gain or loss of function assays. Mechanistic results were concluded by Mass spectroscopy, immunoprecipitation and mutational studies, and functional evaluations.
Results:
We show that the significant decrease in claudin-2 expression characterized PTE cells and Ex-vivo cultured mouse kidney subjected to dedifferentiation. Inhibition of claudin-2 was enough to induce mesenchymal plasticity and invasive mobility in these models. Further, a progressive loss of claudin-2 expression associated with the RCC progression and poor patient survival. Overexpression of claudin-2 in RCC-derived cancer cells inhibited tumorigenic abilities and xenograft tumor growth. These data supported a novel tumor-suppressive role of claudin-2 in RCC. Mechanistic insights further revealed that claudin-2 associates with YAP-protein and modulates its phosphorylation (S127) and nuclear expression. The tumor suppressive effects of claudin-2 expression were lost upon deletion of its PDZ-binding motif emphasizing the critical role of the PDZ-domain in claudin-2 interaction with YAP in regulating RCC malignancy.
Conclusions:
Our results demonstrate a novel kidney specific tumor suppressive role for claudin-2 protein and further demonstrate that claudin-2 co-operates with the YAP signaling in regulating the RCC malignancy.
Insights
Claudin-2 exhibits a novel tumor-suppressive role in kidney cancer, contrasting its role in other cancers. Its interaction with YAP signaling is key to regulating renal clear cell carcinoma (RCC) malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Kidney Disease Research
Background:
- Claudin-2 is upregulated in many cancers, promoting malignancy.
- Its role in kidney cancer is unknown, despite expression in proximal tubular epithelium (PTE), the origin of renal clear cell carcinoma (RCC).
Purpose of the Study:
- To investigate the role of claudin-2 in renal clear cell carcinoma (RCC).
- To elucidate the mechanism of claudin-2 action in kidney cancer.
Main Methods:
- Analysis of patient databases for claudin-2 association with RCC.
- In vitro and in vivo gain/loss of function assays.
- Mass spectrometry, immunoprecipitation, mutational studies, and functional evaluations to determine mechanisms.
Main Results:
- Decreased claudin-2 expression in PTE cells and dedifferentiated kidneys induced mesenchymal plasticity and invasive mobility.
- Loss of claudin-2 correlated with RCC progression and poor survival.
- Claudin-2 overexpression inhibited RCC cell tumorigenicity and xenograft growth, indicating a tumor-suppressive role.
- Claudin-2 interacts with YAP, modulating its phosphorylation and nuclear expression, with the PDZ-binding motif being critical.
Conclusions:
- Claudin-2 has a novel, kidney-specific tumor-suppressive role in RCC.
- Claudin-2 cooperates with YAP signaling to regulate RCC malignancy.
More Related Videos
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Cell Migration through Invadopodia
Tight Junctions
